Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Cash Flow-to-Debt Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥117.38 Million could theoretically repay 0% of its total liabilities (CN¥2.44 Billion) in one year. See Zhangzhou Pientzehuang Pharmaceutical Co free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. Also explore 600436 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year debt coverage analysis for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600436 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | CN¥77.03 Million | CN¥2.47 Billion | ▼ -93.6% |
| 2024 | 0.49x | CN¥1.31 Billion | CN¥2.70 Billion | ▼ -30.3% |
| 2023 | 0.70x | CN¥2.21 Billion | CN¥3.16 Billion | ▼ -71.8% |
| 2022 | 2.47x | CN¥6.87 Billion | CN¥2.78 Billion | ▲ +1161.5% |
| 2021 | 0.20x | CN¥462.27 Million | CN¥2.36 Billion | ▼ -74.0% |
| 2020 | 0.75x | CN¥1.47 Billion | CN¥1.95 Billion | ▲ +257.6% |
| 2019 | -0.48x | CN¥-879.37 Million | CN¥1.84 Billion | ▼ -205.3% |
| 2018 | 0.45x | CN¥612.31 Million | CN¥1.35 Billion | ▼ -18.1% |
| 2017 | 0.55x | CN¥676.93 Million | CN¥1.22 Billion | ▲ +80.6% |
| 2016 | 0.31x | CN¥394.54 Million | CN¥1.29 Billion | ▼ -24.6% |
| 2015 | 0.41x | CN¥305.51 Million | CN¥751.60 Million | ▲ +1.8% |
| 2014 | 0.40x | CN¥264.50 Million | CN¥662.34 Million | ▼ -2.9% |
| 2013 | 0.41x | CN¥274.34 Million | CN¥667.05 Million | ▲ +71.0% |
| 2012 | 0.24x | CN¥162.40 Million | CN¥675.22 Million | ▼ -60.8% |
| 2011 | 0.61x | CN¥232.95 Million | CN¥379.69 Million | ▲ +8.4% |
| 2010 | 0.57x | CN¥205.41 Million | CN¥362.97 Million | ▲ +86.7% |
| 2009 | 0.30x | CN¥129.52 Million | CN¥427.35 Million | ▲ +667.6% |
| 2008 | 0.04x | CN¥12.57 Million | CN¥318.45 Million | ▼ -86.1% |
| 2007 | 0.28x | CN¥60.04 Million | CN¥212.03 Million | ▼ -38.8% |
| 2006 | 0.46x | CN¥50.70 Million | CN¥109.53 Million | ▼ -42.6% |
| 2005 | 0.81x | CN¥69.06 Million | CN¥85.56 Million | ▼ -83.9% |
| 2004 | 5.01x | CN¥98.67 Million | CN¥19.69 Million | ▲ +541.1% |
| 2003 | 0.78x | CN¥32.36 Million | CN¥41.40 Million | ▲ +26.7% |
| 2002 | 0.62x | CN¥105.45 Million | CN¥170.99 Million | ▲ +16.5% |
| 2001 | 0.53x | CN¥65.84 Million | CN¥124.34 Million | — |